Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 10;12(1):58. doi: 10.3390/metabo12010058

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

The ferroptosis inducers and inhibitors used/tested in animal models of kidney disorders, including AKI, DN, CKD, ADPKD, and RCC. AKI: acute kidney injury; DN: diabetic nephropathy; CKD: chronic kidney disease; ADPKD: autosomal dominant polycystic kidney disease; RCC: renal cell carcinoma. Fer-1: Ferrostain-1; DPPD: diphenyl-p-phenylenediamine; NAC: N-acetyl-l-cysteine; ferric ammonium citrate, DFO: deferoxamine mesylate; Rosiglitazone: the inhibitor of ACSL4; DFX: deferasirox; CoQ10: Coenzyme Q10; BSO: L-buthionine (S,R)-sulfoximine.